Motilal Oswal (MOSL) has reiterated its "Buy" rating on HCL Technologies, setting a target price of Rs 2,400, which implies a potential upside of 20% from the current market price of Rs 1,985. Several ...

Viibryd (vilazodone) is a brand-name oral tablet prescribed for depression in adults. The cost of the drug with and without insurance can depend on several factors, such as whether Viibryd has a ...

Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.